KRAS and cancer: The second group belongs to nonhypermutated tumors (~84%) that are microsatellite stable (MSS) cancers with a high frequency of DNA somatic copy number alterations (SCNAs) and dysregulated Wnt pathway with frequent mutations in genes including adenomatous polyposis coli (APC) and Kirsten ras (KRAS).